Pharmacoeconomics and Outcomes Research Iberia-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2019

  1. Second-line treatment with lesinurad and allopurinol versus febuxostat for management of hyperuricemia: a cost-effectiveness analysis for Spanish patients

    Clinical Rheumatology, Vol. 38, Núm. 12, pp. 3521-3528